Kevin Michael Coveney serves as Executive at Enveric Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Kevin Michael Coveney has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 23, 2025 involved receiving (via award) 40,198 shares valued at $0.
Kevin Michael Coveney currently holds 47,413 shares of Enveric Biosciences, Inc. (ENVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Michael Coveney has been a net neutral trader of ENVB stock. They have purchased $0 and sold $0 worth of shares.
Kevin Michael Coveney's most recent insider trade was on Dec 23, 2025, when they sold 40,198 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 13, 2023 | ENVB | $0 | Award | 26,500 | $N/A | Discretionary |